Lupus Research Alliance Report issue

Foundation Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2002
NCT00120887
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Lupus Research Alliance

Active Ingredients

Drugs in Phase 4 Trials (1)

atorvastatin (lipitor) (1 trial)

Drugs in Phase 3 Trials (1)

immune globulin (human) (Gamastan) (1 trial)

Drugs in Phase 2 Trials (2)

benazepril (lotensin) (1 trial)

lisinopril (zestril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 4)

Heart Block (Phase 3)

Lupus Erythematosus, Systemic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4